Information Provided By:
Fly News Breaks for February 7, 2020
Feb 7, 2020 | 09:28 EDT
Needham analyst Laura Martin lowered her price target on WWE (WWE) shares to $55 from $80 after the company reported Q4 revenue and adjusted EBITDA that were below her estimates and cut her 2020 EBITDA estimate to $250M from $385M based on updated management guidance. However, she thinks the recent correction in the stock has been overdone and she keeps a Buy rating on shares of the sport-entertainment company, which she notes is exploring a "transformative" deal based on selling its OTT content rights to the highest bidder. If the OTT Network content is "sold," she believes the bidder will also be the most likely ultimate buyer of WWE. In her "best case" scenario, Amazon (AMZN) would buy out all of WWE's U.S. and offshore rights for WWE's OTT Network, which she contends would put Amazon in the best spot to purchase all of WWE, whenever the McMahon family is ready to exit.
News For WWE;AMZN From the Last 2 Days
Nov 29, 2021 | 15:08 EST
The Federal Trade Commission announced that it is ordering nine large retailers, wholesalers, and consumer good suppliers to provide detailed information that will "help the FTC shed light on the causes behind ongoing supply chain disruptions and how these disruptions are causing serious and ongoing hardships for consumers and harming competition in the U.S. economy." The orders are being sent to Walmart (WMT), Amazon.Com (AMZN), Kroger (KR), C&S Wholesale Grocers, Associated Wholesale Grocers, McLane Co, Procter & Gamble (PG), Tyson Foods (TSN) and Kraft Heinz (KHC). The companies will have 45 days from the date they received the order to respond. "Supply chain disruptions are upending the provision and delivery of a wide array of goods, ranging from computer chips and medicines to meat and lumber. I am hopeful the FTC's new 6(b) study will shed light on market conditions and business practices that may have worsened these disruptions or led to asymmetric effects. The FTC has a long history of pursuing market studies to deepen our understanding of economic conditions and business conduct, and we should continue to make nimble and timely use of these information-gathering tools and authorities," said Chair Khan. Reference Link
Nov 29, 2021 | 12:17 EDT
Get caught up quickly on the top news and calls moving stocks with these Top Fives, as compiled by the editors of The Fly.  1... To see the rest of the story go to See Story Here
Nov 29, 2021 | 09:06 EST
Amazon Web Services an Amazon (AMZN) company announced that Gilead Science (GILD), has selected AWS as its preferred cloud provider. Innovating on AWS and with the help of AWS experts and partners in healthcare and life sciences, Gilead provides its data scientists with the latest advances in machine learning and analytics. These capabilities fuel data-driven decision making across the organization-from biomarker discovery through manufacturing and clinical trial recruitment-and deliver insights that can help Gilead refine its drug pipeline. The company also relies on AWS to host all workloads for its enterprise resource planning transformation project to implement SAP S/4HANA. treat the individual according to their unique needs, not just the disease," said Marc Berson, Senior Vice President and Chief Information Officer at Gilead. "AWS's performance, infrastructure, and scale are the foundations on which we will complete our ERP transformation and become a more efficient, agile, secure, and data-driven business in the cloud." Gilead is reimagining its bioinformatics compute infrastructure in the world's leading cloud. The use of AWS's compute, machine learning, and database capabilities will support the analysis and integration of diverse genomics, imaging, and experimental datasets to support breakthroughs in how Gilead diagnoses and treats diseases. For instance, by securely analyzing deidentified patient genomic data at scale on AWS to reveal patterns, Gilead can uncover insights on how people living with cancer respond to existing therapeutic options, potentially accelerating the discovery of new treatments.
Nov 28, 2021 | 20:07 EST
Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Moderna (MRNA) Chief Medical Officer Paul Burton said he suspects the new omicron coronavirus variant may elude current vaccines, and if so, a reformulated shot could be available early in the new year, Bloomberg's Joe Easton reported. "We should know about the ability of the current vaccine to provide protection in the next couple of weeks," Burton said Sunday on the BBC's "Andrew Marr Show." "If we have to make a brand new vaccine, I think that's going to be early 2022 before that's really going to be available in large quantities," he said. "The remarkable thing about the mRNA vaccines, the Moderna platform, is that we can move very fast," he added. Meanwhile, a senior (AMZN) executive said it remains too early to predict how the Omicron coronavirus variant will impact consumer spending during the holiday season but suggested that shoppers will press ahead for now, Reuters' Mike Spector reports. Clark said he was "incredibly optimistic" about the ability of scientists and pharmaceutical companies that have developed effective vaccines to respond to the new variant while shoppers take stock of developments. 2. Activist investor Ancora Holdings is pushing Berry Global (BERY) to explore a sale, The Wall Street Journal's Cara Lombardo reported. Ancora, which owns about 1% of Berry Global, is urging it to explore strategic alternatives including a possible sale and make other changes, according to a copy of a letter the activist sent to the company's board Sunday that was viewed by The Wall Street Journal. 3. Buying growth stocks when profits are just a rumor can feel like tempting fate. But some companies reward investors' faith, Al Root wrote in this week's edition of Barron's. That looks to be the case with a trio of electric-vehicle makers, namely China's NIO (NIO), XPeng (XPEV), and Li Auto (LI), the author contended. The Chinese EV players will grow sales, on a combined basis, roughly 160% in 2021, leaving them trading at some 6.5 times next year's estimated sales, the publication added. 4. Disney's (DIS) original musical adventure "Encanto" won the Thanksgiving weekend domestic box office, with a Wednesday-Sunday opening of $40.3M. This was the best start of the pandemic era for an animated title, and that includes the $27M for the three-day weekend. Overseas, the movie earned $29.3M for a global total of $69.6M. 5. IBM (IBM) and Gentherm (THRM) saw positive mentions in this week's edition of Barron's.
Nov 28, 2021 | 15:41 EST
Amazon has partnered with Abu Dhabi Investment Office to establish a fulfilment center by 2024 to be built in accordance with the company's carbon-reduction strategies, according to Reuters, citing the Abu Dhabi government's media office. The project will create thousands of jobs, boosting Abu Dhabi's logistics sector and retail ecosystem and will be in line with the UAE's ambition to achieve net-zero emissions by 2050, the media office added. Reference Link